ArticleScientific reports2025
Epidemiological trends and healthcare burden of Kawasaki disease in children under 5 years in Taiwan.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Kawasaki disease (KD) is a systemic pediatric vasculitis with a globally increasing incidence; however, its epidemiological trends in Taiwan remain inadequately characterized. This study aimed to examine the incidence and healthcare demands associated with KD, particularly refractory KD, among children under 5 years of age in Taiwan. A retrospective analysis of the National Health Insurance Research Database was conducted, identifying patients based on International Classification of Diseases codes and intravenous immunoglobulin (IVIG) treatment records from 2009 to 2020. Demographic and clinical characteristics were analyzed, and comparisons were made between refractory and non-refractory KD groups. The incidence of KD increased from 56.13 to 88.76 per 100,000 person-years during the study period, with higher rates observed among males and children younger than 2 years. Seasonal peaks occurred during warmer months, and a higher burden was noted in urbanized northern regions. Refractory KD accounted for 14.2% of cases and was associated with greater healthcare utilization, including additional IVIG courses, longer hospitalization; anticoagulant use (1.34% vs. 0.38%) and coronary angiography (1.26% vs. 0.49%) were higher but infrequent. These findings highlight the rising incidence and medical burden of KD in Taiwan, underscoring the importance of continued surveillance and optimized management strategies for affected children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.